FIRMQUARRY / COMPANY INTELLIGENCE
MCKESSON CORPORATION
Biotechnology & Pharmaceuticals · IRVING, TX · observed recipient location
EXPANSION / MOVEMENT / RETENTION
Company change signals
Probabilities appear only for calibrated, active models with sufficient data. All other labels describe evidence strength.
Geographic expansion outlook
Explore supported destination claims for MCKESSON CORPORATION, not generic hot spots or invented forecasts.
Company facts
- Company industry
- Biotechnology & Pharmaceuticals
- Legal name
- MCKESSON CORPORATION
- Parent company
- Not reported
- Observed geography
- IRVING, TX · Observed recipient location
- Known operating locations
- Not available
- First / latest observed
- Oct 21, 2026 — Nov 3, 2026
Company and locations stay distinct
Location footprint
Only supported operating establishments appear as locations. Procurement work and recipient addresses remain separate evidence.
Locations
No verified or unresolved establishment candidates are linked to this company.
Recent business change
No establishment outcome or indication is stored for this company.
Expansion
- New federal award+0.0
- New federal award+0.0
- New federal award+0.0
- New federal award+0.0
Relocation
Growth
Contraction
Signal coverage and missing inputs
Moves and market changes
Reviewed workforce and economic-development records linked to this legal entity.
Multi-source indication scores
Descriptive expansion indication from 71 deduplicated signals across 1 independent source families. Points apply published evidence caps, reliability, strength, confidence, and 180-day time decay; this is not a probability.
As of Oct 28, 2026 · company-change-indication-v2 · medium evidenceIndividual source-backed indicators
No conservatively linked early indicators are available.
One source-backed chronology
Timeline
Business change, facilities, workforce, corporate events, and government activity appear chronologically.
- GovernmentAward announced
MCKESSON - MAT- FY27 B1
- GovernmentAward announced
B1 MCKESSON NON-CONTRACT FY27 OCT B1 MCKESSON NON-CONTRACT ACCT 010457 - (MULTIPLE INVOICES FOR MEDICATION SHIPMENTS FOR USE IN FY27)
- GovernmentAward increased
MCKESSON MAT/MOUD PHARMACEUTICALS FY 2027
- GovernmentAward increased
FY 27 MCKESSON OPEN MARKET DELIVERY ORDER AGAINST 36W79720D0001, AGAINST CONTROLLED SUBSTANCES FOR FCI EL RENO *PRIOR KNOWLEDGE OF THESE SERVICES ARE APPROVED BY THE CONTRACTING O
- GovernmentAward increased
CONTROLLED MEDICATION OCT 1,2026 - SEP 30, 2027
- GovernmentAward increased
MCKESSON CONTROLLED PHARMACEUTICALS FY 2027
- GovernmentAward announced
MCKESSON CONTROLLED PHARMACEUTICALS FY 2027
- GovernmentAward announced
B1 MCKESSON NON-CONTROLLED AND CONTROLLED SUBSTANCES
- GovernmentAward announced
MCKESSON GENERAL MEDICATION/SUPPLIES FY27 OCT 1,2026 - SEP 30,2027
- GovernmentAward increased
FY27 OCT 26 B7 FSA MCKESSON MAT MEDICATION
- GovernmentAward increased
MCKESSON MAT CONTROLLED SUBSTANCE FY27
- GovernmentAward announced
CONTROLLED MEDICATION OCT 1,2026 - SEP 30, 2027
- GovernmentAward announced
MCKESSON MAT MEDICATIONS OCTOBER TO DECEMBER 2026 FISCAL YEAR 2027 FUND: 1060AD / PROJECT: 90F RP#: 73-FY27
- GovernmentAward announced
MCKESSON MAT CONTROLLED SUBSTANCE FY27
- GovernmentAward announced
B1 MCKESSON NON-CONTROLLED AND CONTROLLED SUBSTANCES
- GovernmentAward increased
RP# MK27-01 MCKESSON REGULAR MEDICATIONS REGULAR MEDICATION FILL OR KILL CONTROLLED SUBSTANCES FOR PENAL INSTITUTION DELIVER TO PHARMACIST ONLY
- GovernmentAward increased
FY27 NOV 26 B7 MCKESSON PRIME 13F
- GovernmentOption exercised
PRIME VENDOR PHARMACEUTICAL CONTRACT DEPARTMENT OF VETERANS AFFAIRS, INTERAGENCY AGREEMENT 943 CONTRACT NUMBER: 36W79720D0001 OPTION PERIOD 3
- GovernmentAward announced
RP# MK27-01 MCKESSON REGULAR MEDICATIONS REGULAR MEDICATION FILL OR KILL CONTROLLED SUBSTANCES FOR PENAL INSTITUTION DELIVER TO PHARMACIST ONLY
- GovernmentAward announced
PRIME VENDOR PHARMACEUTICAL CONTRACT DEPARTMENT OF VETERANS AFFAIRS, INTERAGENCY AGREEMENT 943 CONTRACT NUMBER: 36W79720D0001 OPTION PERIOD 3
- GovernmentAward increased
B1 MCKESSON NON-CONTROLLED AND CONTROLLED SUBSTANCES
- GovernmentAward announced
B1 MCKESSON NON-CONTRACT FY27 OCT B1 MCKESSON NON-CONTRACT ACCT 010457 - (MULTIPLE INVOICES FOR MEDICATION SHIPMENTS FOR USE IN FY27 1-30 NOV)
- GovernmentAward announced
MCKESSON MAT CONTROLLED SUBSTANCE FY27
- GovernmentAward increased
MCKESSON MAT MEDICATIONS OCTOBER TO DECEMBER 2026 FISCAL YEAR 2027 FUND: 1060AD / PROJECT: 90F RP#: 73-FY27
- GovernmentAward increased
MCKESSON MAT CONTROLLED SUBSTANCE FY27
- GovernmentAward announced
FY 2027 ESTIMATE DM GLUCOMETER STRIPS AND SOLUTION FROM MCKESSON
- GovernmentAward announced
MCKESSON PRIME
- GovernmentAward announced
FY 27 MCKESSON OPEN MARKET DELIVERY ORDER AGAINST 36W79720D0001, AGAINST CONTROLLED SUBSTANCES FOR FCI EL RENO *PRIOR KNOWLEDGE OF THESE SERVICES ARE APPROVED BY THE CONTRACTING O
- GovernmentAward increased
MCKESSON - MAT- FY27 B1
- GovernmentAward announced
MCKESSON NON-CONTROLLED PHARMACEUTICALS FY 2027
- GovernmentAward announced
FY27 NOV 26 B7 MCKESSON PRIME 13F
- GovernmentAward increased
MCKESSON NON-CONTROLLED PHARMACEUTICALS FY 2027
- GovernmentOption exercised
PRIME VENDOR PHARMACEUTICAL CONTRACT DEPARTMENT OF VETERANS AFFAIRS, INTERAGENCY AGREEMENT 943 CONTRACT NUMBER: 36W79720D0001 OPTION PERIOD 3
- GovernmentAward announced
PRIME VENDOR PHARMACEUTICAL CONTRACT DEPARTMENT OF VETERANS AFFAIRS, INTERAGENCY AGREEMENT 943 CONTRACT NUMBER: 36W79720D0001 OPTION PERIOD 3
- GovernmentAward increased
NARCOTIC MEDICATIONS FOR OUD/MAT
- GovernmentAward announced
FY27 OCT 26 B7 FSA MCKESSON MAT MEDICATION
- GovernmentAward announced
MCKESSON MAT/MOUD PHARMACEUTICALS FY 2027
- GovernmentAward increased
MCKESSON GENERAL MEDICATION/SUPPLIES FY27 OCT 1,2026 - SEP 30,2027
- GovernmentAward increased
FY 2027 ESTIMATE DM GLUCOMETER STRIPS AND SOLUTION FROM MCKESSON
- GovernmentAward announced
FY27 B1 MCKESSON CONTROL MEDICATION OCT26
- GovernmentAward increased
MCKESSON PRIME
- GovernmentAward announced
NARCOTIC MEDICATIONS FOR OUD/MAT
- GovernmentAward increased
FY27 B1 MCKESSON MEDICATION NOV 26
- GovernmentAward announced
PRIME VENDOR PHARMCEUTICAL CONTRACT INTRAGENCY AGREEMENT 943 CONTRACT # 36W79720D001 MCKESSON-MAT OCT 1, 2026 - SEP 30, 2027
- GovernmentAward announced
MCKESSON CONTROLLED (FSA)MEDICATION FY27 Q1 MEDICATION FOR INMATE POPULATION OCT 1 - DEC 11 2026
- GovernmentAward increased
PRIME VENDOR PHARMCEUTICAL CONTRACT INTRAGENCY AGREEMENT 943 CONTRACT # 36W79720D001 MCKESSON-MAT OCT 1, 2026 - SEP 30, 2027
- GovernmentAward increased
MCKESSON REG MEDICATION FY27Q1 CR - HR 6500 EXP 12.11.2026 MEDICATION FOR INMATE POPULATION 10/01/2026 - 12/11/2026
- GovernmentAward increased
FCC LOMPOC FY27 B1 MCKESSON - OPEN MARKET MOD 1 TO ADD FY27 FUNDS "EO 14398"
- GovernmentAward increased
MCKESSON REGULAR MEDICATION OCTOBER 2026 FISCAL YEAR 2027 RP#: 68-27
- GovernmentAward increased
MCKESSON REGULAR MEDICATION NOVEMBER 2026 FISCAL YEAR 2027 RP#: 68-27
- GovernmentAward announced
PHARMACEUTICALS - NOVEMBER
- GovernmentAward announced
MCKESSON REGULAR MEDICATION NOVEMBER 2026 FISCAL YEAR 2027 RP#: 68-27
- GovernmentAward announced
MCKESSON PURCHASES- REGULAR F27 OCTOBER OTISVILLE: CONTROLLED MEDICATION ACCRUAL, PER IAA 943, VA CONTRACT 36W79720D0001.
- GovernmentAward increased
FCI THREE RIVERS MAT MEDICATION FOR INMATE POPULATION FY27
- GovernmentAward announced
FCI THREE RIVERS MAT MEDICATION FOR INMATE POPULATION FY27
- GovernmentAward announced
FCC LOMPOC FY27 B1 MCKESSON - CONTROLLED MEDICATIONS MOD 1 TO ADD FY27 FUNDS "EO 14398"
- GovernmentAward increased
MCKESSON REGULAR MEDICATION DECEMBER 2026 FISCAL YEAR 2027 RP#: 72-FY27
- GovernmentAward announced
FCC LOMPOC FY27 B1 MCKESSON - OPEN MARKET MOD 1 TO ADD FY27 FUNDS "EO 14398"
- GovernmentAward increased
MCKESSON CONTROLLED (FSA)MEDICATION FY27 Q1 MEDICATION FOR INMATE POPULATION OCT 1 - DEC 11 2026
- GovernmentAward announced
MCKESSON REGULAR MEDICATION OCTOBER 2026 FISCAL YEAR 2027 RP#: 68-27
- GovernmentAward announced
MCKESSON REGULAR MEDICATION DECEMBER 2026 FISCAL YEAR 2027 RP#: 72-FY27
- GovernmentAward announced
MCKESSON REG MEDICATION FY27Q1 CR - HR 6500 EXP 12.11.2026 MEDICATION FOR INMATE POPULATION 10/01/2026 - 12/11/2026
- GovernmentAward increased
NIGHT STOCK INJECTABLES FY27
- GovernmentAward announced
MCKESSON OPEN MARKET Q1 MEDICATION FY27 MEDICATION FOR INMATE POPULATION CR - HR 6500 EXP 12.11.2026
- GovernmentAward increased
MCKESSON OPEN MARKET Q1 MEDICATION FY27 MEDICATION FOR INMATE POPULATION CR - HR 6500 EXP 12.11.2026
- GovernmentAward announced
NIGHT STOCK INJECTABLES FY27
- GovernmentAward announced
FY27 B1 MCKESSON MEDICATION NOV 26
- GovernmentAward announced
FY27 B1 MCKESSON FSA MAT MEDICATIONS CR PERIOD TO COVER 10/1/2026- 12/11/2026
- GovernmentAward announced
MCKESSON FY26 (PARTIAL) MEDICATIONS
- GovernmentAward decreased
MCKESSON FY26 (PARTIAL) MEDICATIONS
- GovernmentAward increased
PRIME MARKET PHARMACEUTICALS - U&O
- GovernmentAward announced
MCKESSON PRIME VENDOR - CRSU
- GovernmentAward announced
PRIME MARKET PHARMACEUTICALS - U&O
- GovernmentAward increased
MCKESSON PRIME VENDOR - CRSU
- GovernmentAward announced
MAIN DA
- GovernmentAward adjusted
ESTIMATED CHARGES FOR REGULAR MEDICATION FY-18 MODP00002 INCREASE IN FUNDING.
- GovernmentAward increased
ESTIMATED CHARGES FOR HEP-C MEDICATION FY-18. MODP00003 TO INCREASE OF FUNDING.
- GovernmentAward announced
ESTIMATED CHARGES FOR HIV MEDICATION 10/01/17 - 08/09/18. MODP00001 DECREASE IN COST.
- GovernmentAward decreased
ESTIMATED CHARGES FOR HIV MEDICATION 10/01/17 - 08/09/18. MODP00001 DECREASE IN COST.
- GovernmentAward decreased
ESTIMATED CHARGES FOR PSYCH MEDICATION FY-18. MOD P00001 DECREASE OF ITEMS USED.
- GovernmentAward announced
ESTIMATED CHARGES FOR NARCOTIC MEDICATION FY-18 MODP00001 TO DECREASE FUNDING.
- GovernmentAward announced
ESTIMATED CHARGES FOR HEP-C MEDICATION FY-18. MODP00001 TO DECREASE FUNDING.
- GovernmentAward announced
ESTIMATED CHARGES FOR REGULAR MEDICATION FY-18 MODP00001 DECREASE FUNDING.
- GovernmentAward announced
ESTIMATED CHARGES FOR PSYCH MEDICATION FY-18. MOD P00001 DECREASE OF ITEMS USED.
- GovernmentAward decreased
ESTIMATED CHARGES FOR HEP-C MEDICATION FY-18. MODP00001 TO DECREASE FUNDING.
- GovernmentAward decreased
ESTIMATED CHARGES FOR NARCOTIC MEDICATION FY-18 MODP00001 TO DECREASE FUNDING.
- GovernmentAward decreased
ESTIMATED CHARGES FOR REGULAR MEDICATION FY-18 MODP00001 DECREASE FUNDING.
- GovernmentAward announced
MCKESSON NARCOTICS MEDICATION
- GovernmentAward decreased
MCKESSON NARCOTICS MEDICATION
- GovernmentAward announced
MCKESSON GENERAL MEDICATION
- GovernmentAward decreased
MCKESSON GENERAL MEDICATION
- GovernmentAward increased
MCKESSON GENERAL MEDICATION
- GovernmentAward announced
IGF::OT::IGF PLEASE MODIFY ABOVE BY INCREASING THE AMOUNT OF THE OBLIGATION BY $121.68. THIS IS DUE TO THE PREVIOUS ESTIMATE BEING TOO LOW. PREVIOUS PO TOTAL: $79,071.15 NEW PO
- GovernmentAward decreased
REGULAR/PHARMACEUTICALS RP0171
- GovernmentAward decreased
REGULAR/PHARMACEUTICALS RP0153
- GovernmentAward announced
REGULAR/PHARMACEUTICALS RP0153
- GovernmentAward announced
REGULAR/PHARMACEUTICALS RP0167
- GovernmentAward decreased
REGULAR/PHARMACEUTICALS RP0167
- GovernmentAward announced
REGULAR/PHARMACEUTICALS RP0171
- GovernmentAward decreased
REGULAR/PHARMACEUTICALS RP0081
- GovernmentAward decreased
REGULAR/PHARMACEUTICALS RP0059
- GovernmentAward decreased
REGULAR/PHARMACEUTICALS RP0144
- GovernmentAward announced
REGULAR/PHARMACEUTICALS RP0059
- GovernmentAward announced
REGULAR/PHARMACEUTICALS RP0144
- GovernmentAward announced
REGULAR/PHARMACEUTICALS RP0081
- GovernmentAward announced
MCKESSON NARCOTICS MEDICATION
- GovernmentAward announced
MCKESSON GENERAL MEDICATION
- GovernmentAward decreased
MCKESSON GENERAL MEDICATION
- GovernmentAward decreased
MCKESSON NARCOTICS MEDICATION
- GovernmentAward decreased
MCKESSON NARCOTICS MEDICATION
- GovernmentAward announced
MCKESSON GENERAL MEDICATION
- GovernmentAward announced
MCKESSON NARCOTICS MEDICATION
- GovernmentAward decreased
MCKESSON GENERAL MEDICATION
- GovernmentAward announced
PHARMACEUTICAL SUPPLIES CORRECTION 8/29/18: TREASURY ACCOUNT SYMBOL ADDED.
- GovernmentAward decreased
PHARMACEUTICAL SUPPLIES CORRECTION 8/29/18: TREASURY ACCOUNT SYMBOL ADDED.
- GovernmentAward announced
HEPATITIS C MEDICATION FOR INMATE COURCIER, B. #27507-047
- GovernmentAward announced
HEPATITIS C MEDICATION FOR INMATE PARTEE, W. #18686-075
- GovernmentAward announced
HEPATITIS C MEDICATION FOR INMATE PINKNEY, R. #13650-035
- GovernmentAward announced
PRESCRIPTION DRUGS
- GovernmentAward announced
MEDICATIONS FOR INMATES AT FDC PHILADELPHIA
- GovernmentAward announced
MEDICATION FOR INMATES AT FCI FAIRTON
- GovernmentAward announced
REQUIRED HEPATITIS C MEDICATION
- GovernmentAward announced
MCKESSON CONTROL SUBSTANCE
- GovernmentAward announced
INMATE MEDICATIONS (CONTROLLED SUBSTANCE)
- GovernmentAward announced
MEDICATIONS
- GovernmentAward announced
MEDICATIONS FOR INMATES AT FDC PHILADELPHIA
- GovernmentAward announced
MEDICATIONS FOR INMATES AT FDC PHILADELPHIA
Disclosed procurement context
Government Business
Money leads this view. Values represent disclosed obligations and procurement amounts—not company revenue.
Global government business
Markets and currencies remain separate; incompatible currencies are never summed.
| Market | Disclosed value | Currency | Latest activity | Processes |
|---|---|---|---|---|
| US | $0 | USD | Dec 1, 2026 | 73 |
Top agencies by net obligations
- 01Department of Justice70 awards$3M
- 02Department of Health and Human Services3 awards$2.3M
Top work locations by net obligations
- 01IRVING, DALLAS, TX38 awards$3.6M
- 02POLACCA, NAVAJO, AZ1 awards$1.6M
- 03FORT DUCHESNE, UINTAH, UT1 awards$650K
- 04ASHLAND, BOYD, KY1 awards$176.2K
- 05O FALLON, SAINT CHARLES, MO1 awards$21K
- 06BENNETTSVILLE, MARLBORO, SC1 awards$663.6
- 07SAINT PAUL, RAMSEY, MN1 awards$37.7
- 08MC CALLA, BIBB, AL2 awards-$3.1K
- 09SAN FRANCISCO, SAN FRANCISCO, CA24 awards-$807.3K
- 10FORREST CITY, SAINT FRANCIS, AR3 awards$0
Latest U.S. awards
Explore the most recent records here, or open the full company archive to filter across all available years.
| Date | Contract | Company | Buyer / agency | Value | Industry | Country / work location | Outlook |
|---|---|---|---|---|---|---|---|
| Dec 1, 2026 | MCKESSON REGULAR MEDICATION DECEMBER 2026 FISCAL YEAR 2027 RP#: 72-FY27 | MCKESSON CORPORATION | Department of Justice | $469.8K | Biotechnology & Pharmaceuticals | IRVING · TX | Insufficient history |
| Nov 1, 2026 | B1 MCKESSON NON-CONTRACT FY27 OCT B1 MCKESSON NON-CONTRACT ACCT 010457 - (MULTIPLE INVOICES FOR MEDICATION SHIPMENTS FOR USE IN FY27 1-30 NOV) | MCKESSON CORPORATION | Department of Justice | $19.9K | Biotechnology & Pharmaceuticals | IRVING · TX | Insufficient history |
| Nov 1, 2026 | PHARMACEUTICALS - NOVEMBER | MCKESSON CORPORATION | Department of Justice | $133.6K | Biotechnology & Pharmaceuticals | IRVING · TX | Insufficient history |
| Nov 1, 2026 | B1 MCKESSON NON-CONTROLLED AND CONTROLLED SUBSTANCES | MCKESSON CORPORATION | Department of Justice | $634K | Biotechnology & Pharmaceuticals | IRVING · TX | Insufficient history |
| Nov 1, 2026 | FY27 NOV 26 B7 MCKESSON PRIME 13F | MCKESSON CORPORATION | Department of Justice | $120K | Biotechnology & Pharmaceuticals | IRVING · TX | Insufficient history |
| Nov 1, 2026 | FY27 B1 MCKESSON MEDICATION NOV 26 | MCKESSON CORPORATION | Department of Justice | $176.2K | Biotechnology & Pharmaceuticals | ASHLAND · KY | Insufficient history |
| Nov 1, 2026 | MCKESSON REGULAR MEDICATION NOVEMBER 2026 FISCAL YEAR 2027 RP#: 68-27 | MCKESSON CORPORATION | Department of Justice | $115.2K | Biotechnology & Pharmaceuticals | IRVING · TX | Insufficient history |
| Oct 20, 2026 | FY 2027 ESTIMATE DM GLUCOMETER STRIPS AND SOLUTION FROM MCKESSON | MCKESSON CORPORATION | Department of Justice | $1.5K | Biotechnology & Pharmaceuticals | IRVING · TX | Insufficient history |
| Oct 20, 2026 | RP# MK27-01 MCKESSON REGULAR MEDICATIONS REGULAR MEDICATION FILL OR KILL CONTROLLED SUBSTANCES FOR PENAL INSTITUTION DELIVER TO PHARMACIST ONLY | MCKESSON CORPORATION | Department of Justice | $8K | Biotechnology & Pharmaceuticals | IRVING · TX | Insufficient history |
| Oct 20, 2026 | NARCOTIC MEDICATIONS FOR OUD/MAT | MCKESSON CORPORATION | Department of Justice | $663.6 | Biotechnology & Pharmaceuticals | BENNETTSVILLE · SC | Insufficient history |
| Oct 19, 2026 | NIGHT STOCK INJECTABLES FY27 | MCKESSON CORPORATION | Department of Justice | $20K | Biotechnology & Pharmaceuticals | IRVING · TX | Insufficient history |
| Oct 1, 2026 | PRIME VENDOR PHARMCEUTICAL CONTRACT INTRAGENCY AGREEMENT 943 CONTRACT # 36W79720D001 MCKESSON-MAT OCT 1, 2026 - SEP 30, 2027 | MCKESSON CORPORATION | Department of Justice | $30K | Biotechnology & Pharmaceuticals | IRVING · TX | Insufficient history |
| Oct 1, 2026 | MCKESSON MAT MEDICATIONS OCTOBER TO DECEMBER 2026 FISCAL YEAR 2027 FUND: 1060AD / PROJECT: 90F RP#: 73-FY27 | MCKESSON CORPORATION | Department of Justice | $22K | Biotechnology & Pharmaceuticals | IRVING · TX | Insufficient history |
| Oct 1, 2026 | MCKESSON REG MEDICATION FY27Q1 CR - HR 6500 EXP 12.11.2026 MEDICATION FOR INMATE POPULATION 10/01/2026 - 12/11/2026 | MCKESSON CORPORATION | Department of Justice | $80K | Biotechnology & Pharmaceuticals | IRVING · TX | Insufficient history |
| Oct 1, 2026 | FY27 B1 MCKESSON CONTROL MEDICATION OCT26 | MCKESSON CORPORATION | Department of Justice | $1K | Biotechnology & Pharmaceuticals | IRVING · TX | Insufficient history |
| Oct 1, 2026 | MCKESSON NON-CONTROLLED PHARMACEUTICALS FY 2027 | MCKESSON CORPORATION | Department of Justice | $200K | Biotechnology & Pharmaceuticals | IRVING · TX | Insufficient history |
| Oct 1, 2026 | MCKESSON MAT/MOUD PHARMACEUTICALS FY 2027 | MCKESSON CORPORATION | Department of Justice | $120K | Biotechnology & Pharmaceuticals | IRVING · TX | Insufficient history |
| Oct 1, 2026 | B1 MCKESSON NON-CONTRACT FY27 OCT B1 MCKESSON NON-CONTRACT ACCT 010457 - (MULTIPLE INVOICES FOR MEDICATION SHIPMENTS FOR USE IN FY27) | MCKESSON CORPORATION | Department of Justice | $19.1K | Biotechnology & Pharmaceuticals | IRVING · TX | Insufficient history |
| Oct 1, 2026 | MCKESSON PURCHASES- REGULAR F27 OCTOBER OTISVILLE: CONTROLLED MEDICATION ACCRUAL, PER IAA 943, VA CONTRACT 36W79720D0001. | MCKESSON CORPORATION | Department of Justice | $130K | Biotechnology & Pharmaceuticals | IRVING · TX | Insufficient history |
| Oct 1, 2026 | MCKESSON MAT CONTROLLED SUBSTANCE FY27 | MCKESSON CORPORATION | Department of Justice | $1.9K | Biotechnology & Pharmaceuticals | IRVING · TX | Insufficient history |
| Oct 1, 2026 | MCKESSON MAT CONTROLLED SUBSTANCE FY27 | MCKESSON CORPORATION | Department of Justice | $10K | Biotechnology & Pharmaceuticals | IRVING · TX | Insufficient history |
| Oct 1, 2026 | FY27 B1 MCKESSON FSA MAT MEDICATIONS CR PERIOD TO COVER 10/1/2026- 12/11/2026 | MCKESSON CORPORATION | Department of Justice | $8.9K | Biotechnology & Pharmaceuticals | IRVING · TX | Insufficient history |
| Oct 1, 2026 | FCC LOMPOC FY27 B1 MCKESSON - CONTROLLED MEDICATIONS MOD 1 TO ADD FY27 FUNDS "EO 14398" | MCKESSON CORPORATION | Department of Justice | $8K | Biotechnology & Pharmaceuticals | IRVING · TX | Insufficient history |
| Oct 1, 2026 | MCKESSON REGULAR MEDICATION OCTOBER 2026 FISCAL YEAR 2027 RP#: 68-27 | MCKESSON CORPORATION | Department of Justice | $384.4K | Biotechnology & Pharmaceuticals | IRVING · TX | Insufficient history |
| Oct 1, 2026 | MCKESSON CONTROLLED PHARMACEUTICALS FY 2027 | MCKESSON CORPORATION | Department of Justice | $10K | Biotechnology & Pharmaceuticals | IRVING · TX | Insufficient history |
| Oct 1, 2026 | MCKESSON PRIME | MCKESSON CORPORATION | Department of Justice | $180K | Biotechnology & Pharmaceuticals | IRVING · TX | Insufficient history |
| Oct 1, 2026 | PRIME VENDOR PHARMACEUTICAL CONTRACT DEPARTMENT OF VETERANS AFFAIRS, INTERAGENCY AGREEMENT 943 CONTRACT NUMBER: 36W79720D0001 OPTION PERIOD 3 | MCKESSON CORPORATION | Department of Justice | $15K | Biotechnology & Pharmaceuticals | IRVING · TX | Insufficient history |
| Oct 1, 2026 | FCC LOMPOC FY27 B1 MCKESSON - OPEN MARKET MOD 1 TO ADD FY27 FUNDS "EO 14398" | MCKESSON CORPORATION | Department of Justice | $20K | Biotechnology & Pharmaceuticals | IRVING · TX | Insufficient history |
| Oct 1, 2026 | FCI THREE RIVERS MAT MEDICATION FOR INMATE POPULATION FY27 | MCKESSON CORPORATION | Department of Justice | $493.6 | Biotechnology & Pharmaceuticals | IRVING · TX | Insufficient history |
| Oct 1, 2026 | MCKESSON - MAT- FY27 B1 | MCKESSON CORPORATION | Department of Justice | $3.8K | Biotechnology & Pharmaceuticals | IRVING · TX | Insufficient history |
| Oct 1, 2026 | PRIME VENDOR PHARMACEUTICAL CONTRACT DEPARTMENT OF VETERANS AFFAIRS, INTERAGENCY AGREEMENT 943 CONTRACT NUMBER: 36W79720D0001 OPTION PERIOD 3 | MCKESSON CORPORATION | Department of Justice | $150K | Biotechnology & Pharmaceuticals | IRVING · TX | Insufficient history |
| Oct 1, 2026 | MCKESSON GENERAL MEDICATION/SUPPLIES FY27 OCT 1,2026 - SEP 30,2027 | MCKESSON CORPORATION | Department of Justice | $10.2K | Biotechnology & Pharmaceuticals | IRVING · TX | Insufficient history |
| Oct 1, 2026 | FY27 OCT 26 B7 FSA MCKESSON MAT MEDICATION | MCKESSON CORPORATION | Department of Justice | $20K | Biotechnology & Pharmaceuticals | IRVING · TX | Insufficient history |
| Oct 1, 2026 | B1 MCKESSON NON-CONTROLLED AND CONTROLLED SUBSTANCES | MCKESSON CORPORATION | Department of Justice | $622.1K | Biotechnology & Pharmaceuticals | IRVING · TX | Insufficient history |
| Oct 1, 2026 | FY 27 MCKESSON OPEN MARKET DELIVERY ORDER AGAINST 36W79720D0001, AGAINST CONTROLLED SUBSTANCES FOR FCI EL RENO *PRIOR KNOWLEDGE OF THESE SERVICES ARE APPROVED BY THE CONTRACTING O | MCKESSON CORPORATION | Department of Justice | $15K | Biotechnology & Pharmaceuticals | IRVING · TX | Insufficient history |
| Oct 1, 2026 | CONTROLLED MEDICATION OCT 1,2026 - SEP 30, 2027 | MCKESSON CORPORATION | Department of Justice | $300 | Biotechnology & Pharmaceuticals | IRVING · TX | Insufficient history |
| Oct 1, 2026 | MCKESSON OPEN MARKET Q1 MEDICATION FY27 MEDICATION FOR INMATE POPULATION CR - HR 6500 EXP 12.11.2026 | MCKESSON CORPORATION | Department of Justice | $2K | Biotechnology & Pharmaceuticals | IRVING · TX | Insufficient history |
| Aug 10, 2026 | MCKESSON CONTROLLED (FSA)MEDICATION FY27 Q1 MEDICATION FOR INMATE POPULATION OCT 1 - DEC 11 2026 | MCKESSON CORPORATION | Department of Justice | $14K | Biotechnology & Pharmaceuticals | IRVING · TX | Insufficient history |
| Apr 1, 2026 | MCKESSON FY26 (PARTIAL) MEDICATIONS | MCKESSON CORPORATION | Department of Justice | Adjusted / no current positive award value reported | Biotechnology & Pharmaceuticals | IRVING · TX | Insufficient history |
| Jul 26, 2022 | MCKESSON PRIME VENDOR - CRSU | MCKESSON CORPORATION | Department of Health and Human Services | $1.6M | Biotechnology & Pharmaceuticals | POLACCA · AZ | Insufficient history |
| Jul 20, 2022 | PRIME MARKET PHARMACEUTICALS - U&O | MCKESSON CORPORATION | Department of Health and Human Services | $650K | Biotechnology & Pharmaceuticals | FORT DUCHESNE · UT | Insufficient history |
| Mar 5, 2020 | MAIN DA | MCKESSON CORPORATION | Department of Health and Human Services | $9.3K | Not reported | IRVING · TX | Insufficient history |
| Sep 18, 2018 | ESTIMATED CHARGES FOR REGULAR MEDICATION FY-18 MODP00002 INCREASE IN FUNDING. | MCKESSON CORPORATION | Department of Justice | Adjusted / no current positive award value reported | Biotechnology & Pharmaceuticals | SAN FRANCISCO · CA | Insufficient history |
| Sep 7, 2018 | ESTIMATED CHARGES FOR HEP-C MEDICATION FY-18. MODP00003 TO INCREASE OF FUNDING. | MCKESSON CORPORATION | Department of Justice | Adjusted / no current positive award value reported | Biotechnology & Pharmaceuticals | SAN FRANCISCO · CA | Insufficient history |
| Sep 4, 2018 | ESTIMATED CHARGES FOR HIV MEDICATION 10/01/17 - 08/09/18. MODP00001 DECREASE IN COST. | MCKESSON CORPORATION | Department of Justice | Adjusted / no current positive award value reported | Biotechnology & Pharmaceuticals | SAN FRANCISCO · CA | Insufficient history |
| Aug 23, 2018 | ESTIMATED CHARGES FOR NARCOTIC MEDICATION FY-18 MODP00001 TO DECREASE FUNDING. | MCKESSON CORPORATION | Department of Justice | Adjusted / no current positive award value reported | Biotechnology & Pharmaceuticals | SAN FRANCISCO · CA | Insufficient history |
| Aug 23, 2018 | ESTIMATED CHARGES FOR PSYCH MEDICATION FY-18. MOD P00001 DECREASE OF ITEMS USED. | MCKESSON CORPORATION | Department of Justice | Adjusted / no current positive award value reported | Biotechnology & Pharmaceuticals | SAN FRANCISCO · CA | Insufficient history |
| Jun 25, 2018 | MCKESSON NARCOTICS MEDICATION | MCKESSON CORPORATION | Department of Justice | Adjusted / no current positive award value reported | Biotechnology & Pharmaceuticals | MC CALLA · AL | Insufficient history |
| Jun 13, 2018 | MCKESSON GENERAL MEDICATION | MCKESSON CORPORATION | Department of Justice | Adjusted / no current positive award value reported | Biotechnology & Pharmaceuticals | SAN FRANCISCO · CA | Insufficient history |
| Jun 13, 2018 | MCKESSON GENERAL MEDICATION | MCKESSON CORPORATION | Department of Justice | Adjusted / no current positive award value reported | Biotechnology & Pharmaceuticals | MC CALLA · AL | Insufficient history |
GOVERNMENT BUSINESS / ANNUAL HISTORY
Annual net U.S. obligations
Disclosed federal transaction obligations, including deobligations. Not company revenue or contract ceiling.
Historical awards and modifications are preserved as individual records.
Browse all company contracts ↗Evidence and identifiers
Sources & Coverage
Technical identifiers live here, with retained official links and visible coverage limitations.
Source identifiers
No source identifiers are available for this legal entity.